Business
Kimball Electronics Reports Q3 Results With Double-Digit Sequential Medical Sales Growth; Company Affirms Guidance for Fiscal 2026 With Adjusted Operating Margin Expected at High End of Range
JASPER, Ind., May 05, 2026--Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the third quarter ended March 31, 2026.
About this update from Kimball Electronics, Inc.
[{"type":"image","alt":"Kimball Electronics Reports Q3 Results With Double-Digit Sequential Medical Sales Growth; Company Affirms Guidance for Fiscal 2026 With Adjusted Operating Margin Expected at High End of Range","displaySize":"","headline":null,"caption":"Kimball Electronics Reports Q3 Results With Double-Digit Sequential Medical Sales Growth; Company Affirms Guidance for Fiscal 2026 With Adjusted Operating Margin Expected at High End of Range","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":405,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/13c0ee2ec6b22d04d459280758dcb2e2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rjlVwNnstvlAlYCvJb.cew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTgzNg--/https://media.zenfs.com/en/business-wire.com/13c0ee2ec6b22d04d459280758dcb2e2","width":405,"height":480}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":10928,"height":2328,"url":"https://media.zenfs.com/en/business-wire.com/3f62eeeb0ba9ab88f853074334648ec3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6lAWmS9tdqlzAqzgp3TSfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwNQ--/https://media.zenfs.com/en/business-wire.com/3f62eeeb0ba9ab88f853074334648ec3","width":960,"height":205},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/xdw9wtQh1F8q0qHAc8dscw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MTI-/https://media.zenfs.com/en/business-wire.com/3f62eeeb0ba9ab88f853074334648ec3","width":1200,"height":256}}},{"type":"text","content":"Third Quarter 2026 Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $352.9 million, a sequential increase of 3.4% compared to Q2","length":71,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Sales in the medical vertical increased 10.2% versus the prior quarter","length":70,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Operating income of $11.8 million, or 3.3% of net sales, adjusted operating margin of 4.2%","length":90,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Cash from operations of $14.9 million, the ninth consecutive quarter of positive operating cash generation","length":106,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Debt of $16...